EUVIMEDScopri EUVIMED
Crossref

Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia

Fang He iD, Yan Tu, Lihong Ni

Hematological Oncology · 2024

DOI: 10.1002/hon.3307 ↗

At a glance

Journal article in Hematological Oncology, 2024. Written by Fang He and 2 co-authors. Institution: Department of Hematology, Jinhua Municipal Central Hospital, Jinhua, China. Major MEDLINE topics: Leukemia, Myeloid, Acute, Histone Deacetylase 2, Cell Differentiation, Homeodomain Proteins. Cited 2 times so far (Crossref); 24 references. Funded by: Jinhua Science and Technology Plan Project.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Homeodomain‐only protein homeobox ( HOPX ) mainly exerts its transcriptional repression by physically sequestering the serum co‐repressor and recruiting histone deacetylase ( HDAC ), possessing important potential as a prognostic gene in acute myeloid leukemia (AML). HDACs play crucial roles in cell growth, gene regulation, and metabolism, and they are also important factors in promoting AML progression. Therefore, this project attempts to investigate whether HOPX affects AML progression by interacting with HDAC2 protein. Bioinformatics analysis was employed to identify potential prognostic genes in AML. Flow cytometry and MTT assays were performed to analyze the cellular biological functions of the AML prognostic marker HOPX . The interaction network of HOPX was analyzed using the Search Tool for the Retrieval of Interacting Genes database, and the interaction between HOPX and HDAC2 was observed using endogenous and exogenous immunoprecipitation. HOPX is highly expressed in AML cells. Further research uncovered that low expression of HOPX can repress the proliferation activity, anti‐apoptotic ability, and differentiation blockage of AML cells. Moreover, mechanistically, HOPX induced AML differentiation blockage and malignant progression through interaction with HDAC. HOPX can serve as a prognostic marker for AML and can interact with HDAC2 to induce AML differentiation blockage and malignant progression.

Subjects

MeSH terms (MEDLINE)

Leukemia, Myeloid, AcuteHistone Deacetylase 2Cell DifferentiationHomeodomain ProteinsHumansCell ProliferationGene Expression Regulation, LeukemicApoptosisCell Line, TumorPrognosisTumor Suppressor Proteins

Author keywords

acute myeloid leukemiadifferentiation blockagehistone deacetylasehomeodomain‐only protein homeoboxprotein interaction

Substances

Histone Deacetylase 2HDAC2 protein, humanHomeodomain ProteinsHOPX protein, humanTumor Suppressor Proteins

Authors and institutions

  • Department of Hematology, Jinhua Municipal Central Hospital, Jinhua, China.

ORCID profiles: Fang He

Funding

  • Jinhua Science and Technology Plan Project

Cite

APA

He, F., Tu, Y., & Ni, L. (2024). Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia. Hematological Oncology. https://doi.org/10.1002/hon.3307

Vancouver

He F, Tu Y, Ni L. Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia. Hematological Oncology. 2024. doi:10.1002/hon.3307

BibTeX
@article{He2024,
  author = {He, Fang and Tu, Yan and Ni, Lihong},
  title = {Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia},
  journal = {Hematological Oncology},
  year = {2024},
  doi = {10.1002/hon.3307}
}
Start for free →